93 related articles for article (PubMed ID: 25372368)
1. Fast identification of novel lymphoid tyrosine phosphatase inhibitors using target-ligand interaction-based virtual screening.
Hou X; Li R; Li K; Yu X; Sun JP; Fang H
J Med Chem; 2014 Nov; 57(22):9309-22. PubMed ID: 25372368
[TBL] [Abstract][Full Text] [Related]
2. Protein Flexibility in Docking-Based Virtual Screening: Discovery of Novel Lymphoid-Specific Tyrosine Phosphatase Inhibitors Using Multiple Crystal Structures.
Hou X; Li K; Yu X; Sun JP; Fang H
J Chem Inf Model; 2015 Sep; 55(9):1973-83. PubMed ID: 26360643
[TBL] [Abstract][Full Text] [Related]
3. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
Yu X; Sun JP; He Y; Guo X; Liu S; Zhou B; Hudmon A; Zhang ZY
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19767-72. PubMed ID: 18056643
[TBL] [Abstract][Full Text] [Related]
4. Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.
Du J; Qiao Y; Sun L; Wang X
Curr Drug Targets; 2014 Mar; 15(3):335-46. PubMed ID: 24188455
[TBL] [Abstract][Full Text] [Related]
5. Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.
Li K; Hou X; Li R; Bi W; Yang F; Chen X; Xiao P; Liu T; Lu T; Zhou Y; Tian Z; Shen Y; Zhang Y; Wang J; Fang H; Sun J; Yu X
J Biol Chem; 2019 May; 294(21):8653-8663. PubMed ID: 30979725
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of imidazolidine-2,4-dione and 2-thioxothiazolidin-4-one derivatives as lymphoid-specific tyrosine phosphatase inhibitors.
Liang X; Fu H; Xiao P; Fang H; Hou X
Bioorg Chem; 2020 Oct; 103():104124. PubMed ID: 32768742
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acids.
Vang T; Xie Y; Liu WH; Vidović D; Liu Y; Wu S; Smith DH; Rinderspacher A; Chung C; Gong G; Mustelin T; Landry DW; Rickert RC; Schürer SC; Deng SX; Tautz L
J Med Chem; 2011 Jan; 54(2):562-71. PubMed ID: 21190368
[TBL] [Abstract][Full Text] [Related]
8. Thiuram disulfides as pseudo-irreversible inhibitors of lymphoid tyrosine phosphatase.
Kulkarni RA; Stanford SM; Vellore NA; Krishnamurthy D; Bliss MR; Baron R; Bottini N; Barrios AM
ChemMedChem; 2013 Sep; 8(9):1561-8. PubMed ID: 23873737
[TBL] [Abstract][Full Text] [Related]
9. Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.
Karver MR; Krishnamurthy D; Bottini N; Barrios AM
J Inorg Biochem; 2010 Mar; 104(3):268-73. PubMed ID: 20083307
[TBL] [Abstract][Full Text] [Related]
10. Covalent inhibition of the lymphoid tyrosine phosphatase.
Ahmed VF; Bottini N; Barrios AM
ChemMedChem; 2014 Feb; 9(2):296-9. PubMed ID: 24403103
[TBL] [Abstract][Full Text] [Related]
11. Distinct functional and conformational states of the human lymphoid tyrosine phosphatase catalytic domain can be targeted by choice of the inhibitor chemotype.
Vidović D; Xie Y; Rinderspacher A; Deng SX; Landry DW; Chung C; Smith DH; Tautz L; Schürer SC
J Comput Aided Mol Des; 2011 Sep; 25(9):873-83. PubMed ID: 21904909
[TBL] [Abstract][Full Text] [Related]
12. The autoimmunity risk variant LYP-W620 cooperates with CSK in the regulation of TCR signaling.
de la Puerta ML; Trinidad AG; Rodríguez Mdel C; de Pereda JM; Sánchez Crespo M; Bayón Y; Alonso A
PLoS One; 2013; 8(1):e54569. PubMed ID: 23359562
[TBL] [Abstract][Full Text] [Related]
13. Target-specific control of lymphoid-specific protein tyrosine phosphatase (Lyp) activity.
Walton ZE; Bishop AC
Bioorg Med Chem; 2010 Jul; 18(14):4884-91. PubMed ID: 20594861
[TBL] [Abstract][Full Text] [Related]
14. In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation.
Wu S; Bottini M; Rickert RC; Mustelin T; Tautz L
ChemMedChem; 2009 Mar; 4(3):440-4. PubMed ID: 19177473
[TBL] [Abstract][Full Text] [Related]
15. The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses.
Vang T; Landskron J; Viken MK; Oberprieler N; Torgersen KM; Mustelin T; Tasken K; Tautz L; Rickert RC; Lie BA
Hum Immunol; 2013 May; 74(5):574-85. PubMed ID: 23333624
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and functional studies of lymphoid-specific tyrosine phosphatase (Lyp) variants S201F and R266W.
Liu J; Chen M; Li R; Yang F; Shi X; Zhu L; Wang HM; Yao W; Liu Q; Meng FG; Sun JP; Pang Q; Yu X
PLoS One; 2012; 7(8):e43631. PubMed ID: 22952725
[TBL] [Abstract][Full Text] [Related]
17. LYP inhibits T-cell activation when dissociated from CSK.
Vang T; Liu WH; Delacroix L; Wu S; Vasile S; Dahl R; Yang L; Musumeci L; Francis D; Landskron J; Tasken K; Tremblay ML; Lie BA; Page R; Mustelin T; Rahmouni S; Rickert RC; Tautz L
Nat Chem Biol; 2012 Mar; 8(5):437-46. PubMed ID: 22426112
[TBL] [Abstract][Full Text] [Related]
18. A three-dimensional chemical phase pharmacophore mapping, QSAR modelling and electronic feature analysis of benzofuran salicylic acid derivatives as LYP inhibitors.
Suryanarayanan V; Singh SK; Tripathi SK; Selvaraj C; Reddy KK; Karthiga A
SAR QSAR Environ Res; 2013; 24(12):1025-40. PubMed ID: 23987088
[TBL] [Abstract][Full Text] [Related]
19. A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases.
He Y; Liu S; Menon A; Stanford S; Oppong E; Gunawan AM; Wu L; Wu DJ; Barrios AM; Bottini N; Cato AC; Zhang ZY
J Med Chem; 2013 Jun; 56(12):4990-5008. PubMed ID: 23713581
[TBL] [Abstract][Full Text] [Related]
20. Proline-serine-threonine phosphatase interacting protein 1 inhibition of T-cell receptor signaling depends on its SH3 domain.
Marcos T; Ruiz-Martín V; de la Puerta ML; Trinidad AG; Rodríguez Mdel C; de la Fuente MA; Sánchez Crespo M; Alonso A; Bayón Y
FEBS J; 2014 Sep; 281(17):3844-54. PubMed ID: 25040622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
